An imidazolylpyrimidine was identified in a CXCR2 chemokine receptor antagonist screen and was optimized for potency, in vitro metabolic stability, and oral bioavailability. It was found that subtle structural modification within the series affected the oral bioavailability. Potent and orally available CXCR2 antagonists are herein reported.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2006.02.028 | DOI Listing |
Publication Analysis
Top Keywords
cxcr2 chemokine
8
chemokine receptor
8
oral bioavailability
8
imidazolylpyrimidine based
4
based cxcr2
4
receptor antagonists
4
antagonists imidazolylpyrimidine
4
imidazolylpyrimidine identified
4
identified cxcr2
4
receptor antagonist
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!